Related Experiment Videos
Pacing in cardiomyopathy
1Cardiovascular Center Aalst, Belgium. marc.goethals@olvz-aalst.be
Insights
Permanent cardiac pacing helps prevent fainting and sudden death in heart conditions. However, its use in cardiomyopathy patients is debated due to limited, disappointing evidence from randomized studies.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Permanent cardiac pacing is a standard treatment for heart block and sinus node disease.
- Emerging evidence suggests pacing may benefit patients with hypertrophic, dilated, or tachycardia-induced cardiomyopathy.
Purpose of the Study:
- To review the current evidence and indications for cardiac pacing in patients with cardiomyopathy.
- To address the controversy surrounding pacing in these patient populations.
Main Methods:
- Review of existing literature, including retrospective, uncontrolled, and randomized investigations.
- Analysis of data from scarce randomized trials on pacing in cardiomyopathy.
Main Results:
- Evidence supporting pacing in cardiomyopathy is primarily from retrospective and uncontrolled studies.
- Data from limited randomized investigations have yielded disappointing results.
Conclusions:
- The indications for cardiac pacing in patients with cardiomyopathy remain controversial.
- Further high-quality randomized trials are needed to clarify the role of pacing in cardiomyopathy.
Abstract:
Permanent cardiac pacing is an established treatment for the prevention of syncope or sudden death in patients with heart block or sinus node disease. Recent observations underscore the use of pacing in patients with various forms of cardiomyopathy, i.e. hypertrophic, dilated and tachycardia-induced cardiomyopathy. The evidence favouring the use of pacing in patients with cardiomyopathy is mainly derived from retrospective and uncontrolled investigations and the data from the scarce randomized investigations are rather disappointing. Therefore, the indications for pacing remain controversial.